December 11, 2025

What Drives Progression Despite TNFi?

Study shows complement activation marker C3dg, MASP-1, and MASP-3 levels before tumor necrosis factor inhibitor therapy predicted new bone formation after 2 years of follow-up among axial spondyloarthritis patients with a high risk of radiographic progression.

Conexiant

December 10, 2025

A New Question for Chronic Pain

A new clinical feature–based self-referral tool shows promise for speeding the diagnosis of axial spondyloarthritis.

Conexiant

December 10, 2025

Dual Therapy Shows Bone Promise

Adding romosozumab to ongoing denosumab therapy boosted bone formation and improved spine density in postmenopausal women with severe osteoporosis.

Conexiant

December 08, 2025

RA Clues Detected Months Prior

Key markers signaled RA risk earlier than expected in relatives of adults with RA.

Conexiant

December 08, 2025

The Case of the Hospital That Isn’t

A bureaucratic showdown over North Carolina’s certificate-of-need laws has stalled a critical hospital project, straining care in the state’s mountain communities.

Conexiant

November 21, 2025

EULAR: Issues With the RA Definition?

Researchers examine the strengths and shortcomings of the current European Alliance of Associations for Rheumatology definition for difficult-to-treat rheumatoid arthritis.

Conexiant

November 20, 2025

Severe Infection: Are Hidden Immune Signals Emerging?

Researchers identify four reproducible immune endotypes across sepsis and critical illness.

Conexiant

November 20, 2025

Top 10 States to Practice Internal Medicine

The following list highlights the states that offer the most favorable conditions for internal medicine physicians.

Conexiant

November 19, 2025

HLA Variants Linked to Allopurinol SCAR Risk

Researchers identify HLA-associated risks for allopurinol-induced severe cutaneous adverse reactions in a diverse US population.

Conexiant